• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Ironwood Pharmaceuticals Inc

+ Add to Watchlist

IRWD:US

13.0600 USD 0.1050 0.81%

As of 20:10:00 ET on 10/01/2014.

Snapshot for Ironwood Pharmaceuticals Inc (IRWD)

Open: 12.9800 Day's Range: 12.7000 - 13.1200 Volume: 1,251,110
Previous Close: 12.9550 52wk Range: 8.9500 - 15.9500 1-Yr Rtn: +7.58%

Stock Chart for IRWD

No chart data available.
  • IRWD:US 13.0600
  • 1D
  • 1M
  • 1Y
12.9550
Interactive IRWD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IRWD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7600
Est. EPS (USD) (12/2014) -1.3440
Est. PEG Ratio -
Market Cap (M USD) 1,820.02
Shares Outstanding (M) 120.87
30 Day Average Volume 1,087,621
Price/Book (mrq) 12.8116
Price/Sale (ttm) 53.4238
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/22/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IRWD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IRWD

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of cholesterol, gastrointestinal and cardiovascular diseases, pain, inflammation, and others.

Peter M HechtCEO/Co-FounderMichael J HigginsChief Operating Officer
Halley E GilbertSenior VP/Chief Legal OfcrMark G CurrieSenior VP/Pres:Research & Dev
More Company Profile & Key Executives for IRWD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil